HAA-09 - CAS 1422051-33-9

HAA-09, an orally administered compound, serves as a powerful anti-influenza agent by targeting the influenza PB2_cap binding domain. It possesses significant activity against influenza A virus, exhibiting an EC50 of 0.03 μM, and demonstrates polymerase inhibition with an IC50 of 0.06±0.004 μM. Importantly, HAA-09 inhibits virus replication efficiently without inducing noticeable cytotoxicity [1].

Virus Protease, Influenza Virus, Others

Others, Microbiology/Virology

1422009

C17H18F2N6O2

376.36

FC=1C=C2C(=CNC2=NC1)C=3NC(=NN(CC(O)=O)C(C)(C)C)C(F)=CN3

-20°C

Ice Packs

Small Compound